Clinical Trial Site Identification & Selection

Experts at Chiron Medical can help you to find and select the best clinical trial sites based on sites' therapeutic area experience and their locations in Turkiye.

A clinical trial's ability to succeed depends critically on the identification and selection of the best sites, Key Investigators, and Opinion Leaders. Our powerful and established relationships with experienced investigators help to enable us a timely but comprehensive feasibility assessment to ensure the most appropriate and best recruiting sites are chosen for the clinical trials in Turkiye.

Chiron Medical initiates the process of identifying, qualifying, and selecting clinical trial sites at feasibility and keep going until the project is launched. In order to make sure that every study has the best possible start, Chiron Medical helps the sponsors through the following steps.

Strategic Sites, Scientific Triumphs: Unleashing Potential in Research.

Site Selection, Strategic Excellence: Chiron Medical at Your Service.

Clinical Trial Site Identification

To find the most potential clinical trial site for your study, Chiron Medical will use its extensive local site relationships—developed over 15 years—with experts in a variety of therapeutic fields at training and research hospitals, university hospitals, and private hospitals.
Chiron Medical will use early feasibility results to identify potential clinical trial sites. PI experience, clinical trial site experience, and patient demographics will all be generated through the use of business intelligence tools and the PI database as resources.

Clinical Trial Site Qualification

Chiron Medical will hold site-specific discussions for the trials, emphasizing risk areas found in feasibility assessments.
Interviews with clinical trial sites will be conducted to learn more about each site's infrastructure, patient population diversity and dynamics, and practice referrals.

Chiron Medical will observe competitive trials in-depth and assess the level of dedication of the PI and study personnel.

Chiron Medical: Your Partner in Elevating Trials Through Rigorous Site Qualification.

Chiron Medical: Where Strategy Meets Excellence in Site Selection.

Clinical Trial Site Selection

We will work with sponsors to select the best clinical sites for the trial, utilizing all the data collected in the previously outlined processes.
To make sure objectives are met, every step will be constantly monitored. Upon completion of this process, each study will have chosen its clinical trial sites based on the best fit between therapeutic experience, patient demographic, subject recruitment ability, and ability/history of high-quality execution.
The investigator database at Chiron Medical (over 9,000 investigators) including over provides support to the feasibility process and contains data on the following key parameters.
• Potential patients per clinical trial site (81 cities with a combined population of about 86 million in Turkiye)
• Concurrent and competitive studies
• Clinical trial site staff availability
• Predicted degree of dedication to the trial
• Previous performance on similar studies
• Expected investigator fees and budget negotiation